The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDGOC.L Regulatory News (DGOC)

  • There is currently no data for DGOC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Placing

13 Dec 2018 08:18

RNS Number : 3683K
Diversified Gas & Oil PLC
13 December 2018
 

13 December 2018

THIS ANNOUNCEMENT, INCLUDING THE APPENDICES AND THE INFORMATION CONTAINED HEREIN, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

THIS ANNOUNCEMENT HAS NOT BEEN APPROVED BY THE LONDON STOCK EXCHANGE PLC, NOR IS IT INTENDED THAT IT WILL BE SO APPROVED.

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE ANY INVITATION, SOLICITATION, RECOMMENDATION, PROSPECTUS, OFFERING MEMORANDUM, OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES IN DIVERSIFIED GAS & OIL PLC OR ANY OTHER ENTITY IN ANY JURISDICTION. NEITHER THIS ANNOUNCEMENT NOR THE FACT OF ITS DISTRIBUTION SHOULD FORM THE BASIS OF, OR BE RELIED ON IN CONNECTION WITH, ANY INVESTMENT DECISION IN RESPECT OF DIVERSIFIED GAS & OIL PLC OR OTHER EVALUATION OF ANY SECURITIES IN DIVERSIFIED GAS & OIL PLC OR ANY OTHER ENTITY.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU No. 596/2014) ("MAR"). IN ADDITION, MARKET SOUNDINGS (AS DEFINED IN MAR) WERE TAKEN IN RESPECT OF CERTAIN OF THE MATTERS CONTAINED IN THIS ANNOUNCEMENT, WITH THE RESULT THAT CERTAIN PERSONS BECAME AWARE OF SUCH INSIDE INFORMATION, AS PERMITTED BY MAR. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN AND SUCH PERSONS SHALL THEREFORE CEASE TO BE IN POSSESSION OF INSIDE INFORMATION.

PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

 

Result of placing of existing ordinary shares in Diversified Gas & Oil PLC

("DGOC" or the "Company")

Further to the announcement released on 12 December 2018, the Company announces that affiliates of Trive Capital (Trive Capital Fund II and TCFII Core SPV LP or the "Seller"), subject to completion, have sold in aggregate 22,500,000 ordinary shares in the capital of the Company at a price of 114 pence per share (the "Placing"), raising aggregate gross proceeds of £25,650,000 million.

 

Following completion of the Placing, the Seller will hold 7,372,974 ordinary shares in the Company. The ordinary shares in DGOC that the Seller continues to hold are subject to the original lock-in agreements, agreed on 10 October 2018, as part of Core Appalachia acquisition.

 

The trade date for the Placing will be 13 December 2018 and settlement is expected to occur on 31 December 2018 on a T+10 basis, subject to the transfer of US-held shares to the UK-based registrar. The proceeds from the Placing are payable in cash.

 

The Company is not a party to the Placing and will not receive any proceeds from the Placing.

 

Stifel Nicolaus Europe Limited ("Stifel") and Mirabaud Securities ("Mirabaud") acted as Joint Bookrunners in connection with the Placing.

 

For further information, please contact:

 

Cenkos Securities plc

(Nominated Adviser)

Russell Cook

Katy Birkin

 

+44 (0)20 7397 8900

 

Mirabaud Securities Limited

(Joint Broker)

Peter Krens

Edward Haig-Thomas

 

+44 (0)20 3167 7221

 

Stifel Nicolaus Europe Limited

(Joint Broker)

Ashton Clanfield

Callum Stewart

Nicholas Rhodes

 

+44 (0)20 7710 7600

 

IMPORTANT NOTICE

Solely for the purposes of the product governance requirements contained within: (a) EU Directive 2014/65/EU on markets in financial instruments, as amended ("MiFID II"); (b) Articles 9 and 10 of Commission Delegated Directive (EU) 2017/593 supplementing MiFID II; and (c) local implementing measures (together, the "Product Governance Requirements"), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any "manufacturer" (for the purposes of the Product Governance Requirements) may otherwise have with respect thereto, the Placing Shares have been subject to a product approval process, which has determined that the Placing Shares are: (i) compatible with an end target market of retail investors and investors who meet the criteria of professional clients and eligible counterparties, each as defined in MiFID II; and (ii) eligible for distribution through all distribution channels as are permitted by MiFID II (the "Target Market Assessment"). Notwithstanding the Target Market Assessment, Placees should note that: the price of the Placing Shares may decline and investors could lose all or part of their investment; Placing Shares offer no guaranteed income and no capital protection; and an investment in Placing Shares is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom. The Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the Placing. Furthermore, it is noted that, notwithstanding the Target Market Assessment, the Banks will only procure investors who meet the criteria of professional clients and eligible counterparties. For the avoidance of doubt, the Target Market Assessment does not constitute: (a) an assessment of suitability or appropriateness for the purposes of MiFID II; or (b) a recommendation to any investor or group of investors to invest in, or purchase, or take any other action whatsoever with respect to Placing Shares.

In member states of the European Economic Area ("EEA") which have implemented the Prospectus Directive (each, a "Relevant Member State"), this announcement and any offer of Placing Shares if made subsequently is directed exclusively at persons who are "qualified investors" within the meaning of the Prospectus Directive ("Qualified Investors"). For these purposes, the expression "Prospectus Directive" means Directive 2003/71/EC (and amendments thereto, including Directive 2010/73/EU, to the extent implemented in a Relevant Member State), and includes any relevant implementing measure in the Relevant Member State. In the United Kingdom this announcement is only being distributed to, and is only directed at, and any investment or investment activity to which this announcement relates is available only to, and will be engaged in only with, Qualified Investors who are (i) investment professionals falling with Article 19(5) of the UK Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the "Order"); or (ii) high net worth entities falling within Article 49(2)(a) to (d) of the Order, or (iii) other persons to whom an offer of the Placing Shares may otherwise be lawfully communicated (all such persons together being referred to as "relevant persons"). Persons who are not relevant persons should not take any action on the basis of this announcement and should not act or rely on it.

No prospectus or offering document has been or will be prepared in connection with the Placing. Any investment decision in connection with the Placing must be made on the basis of all publicly available information relating to DGOC and DGOC's shares. Such information has not been independently verified by the Seller, Stifel, Mirabaud or any of their respective affiliates. The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy or completeness.

In connection with the Placing, Joint Bookrunners and any of their affiliates may take up a portion of the Placing Shares as a principal position and in that capacity may retain, purchase, sell, offer to sell for their own accounts such Placing Shares and other securities of DGOC or related investments in connection with the Placing or otherwise. Accordingly, references to the shares being issued, offered, subscribed, acquired, placed or otherwise dealt in should be read as including any issue or offer to, or subscription, acquisition, placing or dealing by Joint Bookrunners and any of their affiliates acting as investors for their own accounts. Joint Bookrunners and any of their affiliates do not intend to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligations to do so.

This announcement does not purport to identify or suggest the risks (direct or indirect) which may be associated with an investment in DGOC or DGOC's shares. Stifel and Mirabaud are authorised and regulated in the United Kingdom by the Financial Conduct Authority. Joint Bookrunners and any of their affiliates are acting for the Seller only in connection with the Placing and no one else, and will not be responsible to anyone other than the Seller for providing the protections offered to clients of Joint Bookrunners and any of their affiliates, nor for providing advice in relation to the Placing Shares or the Placing.

Neither the Seller nor any of its directors, partners, officers, employees, advisers or agents accepts any responsibility or liability whatsoever for or makes any representation or warranty, express or implied, as to the truth, accuracy or completeness of the information in this announcement (or whether any information has been omitted from the announcement) or any information relating to DGOC or its subsidiaries or associated companies, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of this announcement or its contents or otherwise arising in connection therewith.

The Placing Shares have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold, directly or indirectly, in the United States, absent registration under or an exemption from, or transaction not subject to, the registration requirements of, the Securities Act. No public offering of securities is being made in the United States or in any other jurisdiction.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROIGGGAGPUPRURW
Date   Source Headline
6th May 20214:27 pmRNSChange of Corporate Name
30th Apr 202112:56 pmRNSREPLACEMENT: Acquisition and Trading Update
30th Apr 20217:01 amRNSAcquisition Announcement and Trading Update
30th Apr 20217:00 amRNSFirst Quarter Dividend Announcement
27th Apr 20213:22 pmRNSResults of Annual General Meeting
23rd Apr 20217:08 amRNSChange in Director Particulars
8th Apr 20217:00 amRNSBorrowing Base Reaffirmation
1st Apr 20217:00 amRNSAnnual Report and Accounts and Notice of AGM
31st Mar 20217:00 amRNSTotal Voting Rights
12th Mar 20217:00 amRNSExercise of Stock Options
12th Mar 20217:00 amRNSQ3 2020 Dividend Exchange Rate
8th Mar 20217:00 amRNSFinal Results for the Year Ended 31 December 2020
1st Mar 20217:00 amRNSVesting of Restricted Stock Units, PDMR and TVR
23rd Feb 20217:00 amRNSNotification of Major Holdings
17th Feb 20217:00 amRNSNotification of Major Holdings
29th Jan 20217:00 amRNSTotal Voting Rights
27th Jan 20217:00 amRNSTrading Statement and Cancellation of Warrants
4th Jan 20217:00 amRNSVesting of Restricted Stock Units
4th Dec 20207:00 amRNSQ2 2020 Dividend Exchange Rate
2nd Dec 20207:00 amRNSNOTIFICATION OF MAJOR HOLDINGS
30th Nov 20207:00 amRNSTotal Voting Rights
23rd Nov 20207:00 amRNSBorrowing Base Reaffirmation
16th Nov 20207:00 amRNSDirector/PDMR Shareholding
9th Nov 20205:45 pmRNSVesting of Restricted Stock Units
9th Nov 20205:43 pmRNSDirector/PDMR Shareholdings
2nd Nov 20207:01 amRNSVesting of Restricted Stock Units
2nd Nov 20207:00 amRNSDirector/PDMR Shareholdings
29th Oct 20207:00 amRNSThird Quarter Dividend Announcement
29th Oct 20207:00 amRNSTrading Update
12th Oct 20207:00 amRNSNotification of Major Holdings
6th Oct 20207:00 amRNSDirector/PDMR Shareholdings
5th Oct 20207:00 amRNSDGO Announces Strategic Participation Agreement
22nd Sep 20207:01 amRNSNOTIFICATION OF MAJOR HOLDINGS
21st Sep 20207:00 amRNSNotification of Major Holdings
18th Sep 20207:01 amRNSNOTIFICATION OF MAJOR HOLDINGS
17th Sep 20207:01 amRNSNOTIFICATION OF MAJOR HOLDINGS
15th Sep 20207:01 amRNSNOTIFICATION OF MAJOR HOLDINGS
15th Sep 20207:00 amRNSUpcoming Dividend Exchange Rate
3rd Sep 20207:00 amRNSNotification of Major Holdings
3rd Sep 20207:00 amRNSFTSE 250 Index Inclusion
1st Sep 20207:00 amRNSNotification of Major Holdings
1st Sep 20207:00 amRNSTotal Voting Rights
21st Aug 20201:07 pmRNSDirector/PDMR Shareholding
12th Aug 20207:00 amRNSNotification of Major Holdings
10th Aug 20207:01 amRNSInterim Results
10th Aug 20207:00 amRNSSecond Quarter 2020 Dividend Announcement
3rd Aug 20207:00 amRNSVesting of RSU PDMR Share Dealings
31st Jul 20207:00 amRNSTotal Voting Rights
14th Jul 20207:00 amRNSNotice of Interim Results
2nd Jul 202012:06 pmRNSVesting of Restricted Stock Units, PDMR and TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.